THOMAS KOSTEN to Receptors, N-Methyl-D-Aspartate
This is a "connection" page, showing publications THOMAS KOSTEN has written about Receptors, N-Methyl-D-Aspartate.
Connection Strength
0.259
-
Long-Term Safety and Efficacy of Esmethadone in Patients With Major Depressive Disorder: Findings From a 12-Month Open-Label Study. J Clin Psychiatry. 2025 Feb 17; 86(1).
Score: 0.212
-
The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users. Transl Psychiatry. 2023 06 07; 13(1):192.
Score: 0.047